AIM: Talking Points About GBS and J&J Vaccine

This talking points document was developed by iREACH Subject Matter Experts to provide information on the few cases of GBS reported in individuals who received the J & J COVID-19 vaccines.

VAC Southwest/Beaches Profiles 2024

As part of the Vaccine Access Cooperative (VAC) project, this collection of jurisdiction profiles details AIM’s Southwest/Beaches region.

Adolescent Immunization Toolkit

Adolescent Immunization Toolkit

On July 9, 2025, the U.S. Food and Drug Administration (FDA) released its decision to approve the supplemental Biologics License Application (BLA) for SPIKEVAX, but only for use in individuals…

Back To Top
Search